Adial Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.5M | $6.1M |
| FY2022 | — | $3.3M | $4.0M |
| FY2023 | — | $4.1M | $2.8M |
| FY2024 | — | $4.1M | $3.8M |
| FY2025 | — | $5.3M | $5.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.5M | $6.1M |
| FY2022 | — | $3.3M | $4.0M |
| FY2023 | — | $4.1M | $2.8M |
| FY2024 | — | $4.1M | $3.8M |
| FY2025 | — | $5.3M | $5.9M |